SAN

82.47

+0.33%↑

MRK1

119.85

+0.76%↑

SHL.DE

44.33

-0.87%↓

ARGX

734

+1.1%↑

FRE

48.33

+0.86%↑

SAN

82.47

+0.33%↑

MRK1

119.85

+0.76%↑

SHL.DE

44.33

-0.87%↓

ARGX

734

+1.1%↑

FRE

48.33

+0.86%↑

SAN

82.47

+0.33%↑

MRK1

119.85

+0.76%↑

SHL.DE

44.33

-0.87%↓

ARGX

734

+1.1%↑

FRE

48.33

+0.86%↑

SAN

82.47

+0.33%↑

MRK1

119.85

+0.76%↑

SHL.DE

44.33

-0.87%↓

ARGX

734

+1.1%↑

FRE

48.33

+0.86%↑

SAN

82.47

+0.33%↑

MRK1

119.85

+0.76%↑

SHL.DE

44.33

-0.87%↓

ARGX

734

+1.1%↑

FRE

48.33

+0.86%↑

Home・Akciju saraksts・Vetoquinol SA

Vetoquinol SA

Slēgts

SektorsVeselības aprūpe

78.9 1.68

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

78.8

Max

80.4

Galvenie mērījumi
By Trading Economics
Ienākumi	-9.8M 25M
Pārdošana	-17M 258M
P/E Sektora vidējais	15.235 76.798
Dividenžu ienesīgums	1.16
Peļņas marža	9.734
Darbinieki	2,497
EBITDA	-12M 48M

Dividendes
By Dow Jones
Dividenžu ienesīgums Sektora vidējais	1.16% 2.37%
Nākamie ieņēmumi	2026. g. 19. marts

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	9.7M 919M
Iepriekšējā atvēršanas cena	77.22
Iepriekšējā slēgšanas cena	78.9

Ziņu noskaņojums

By Acuity

25%

75%

47 / 374 Rangs Healthcare

Tehniskais rādītājs

By Trading Central

Pārliecība

Bearish Evidence

72.6 / 75.1 Atbalsts un pretestība

Vetoquinol SA Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 19. dec. 17:29 UTC

Iegādes, apvienošanās, pārņemšana

Union Pacific, Norfolk Southern File for Merger Approval From Surface Transportation Board -- 2nd Update

2025. g. 19. dec. 16:47 UTC

Galvenie tirgus virzītāji

Galectin Shares Fall After FDA Raises Issues With Belapectin Program

2025. g. 19. dec. 16:10 UTC

Iegādes, apvienošanās, pārņemšana

Union Pacific, Norfolk Southern File for Merger Approval From Surface Transportation Board -- Update

2025. g. 19. dec. 22:33 UTC

Peļņas

Volkswagen Halts Imports of Its Electric Bus to U.S. Next Year -- WSJ

2025. g. 19. dec. 22:19 UTC

Peļņas

FedEx Earnings Were Strong. Cost Cuts and Shipment Volume Helped. -- Barrons.com

2025. g. 19. dec. 21:48 UTC

Iegādes, apvienošanās, pārņemšana

Trump Media Is Making a Big Pivot. Kodak Tried That, Too. -- Barrons.com

2025. g. 19. dec. 21:44 UTC

Peļņas

These Stocks Moved the Most Today: Oracle, Nike, Micron, DJT, Carnival, BioMarin, CoreWeave, Lamb Weston, and More -- Barrons.com

2025. g. 19. dec. 21:38 UTC

Peļņas

Get Ready for New Chip Shortages. Micron's Success All But Guarantees It. -- Barrons.com

2025. g. 19. dec. 21:00 UTC

Tirgus saruna

BEA's Trade-Data Catchup Will Continue Into January -- Market Talk

2025. g. 19. dec. 20:23 UTC

Tirgus saruna

Oil Futures End Down Week on Up Note -- Market Talk

2025. g. 19. dec. 20:14 UTC

Tirgus saruna

U.S. Natural Gas Futures Post Daily Gain, Weekly Loss -- Market Talk

2025. g. 19. dec. 18:38 UTC

Tirgus saruna

U.S. Oil Rig Count Falls By 8 to 406 -- Market Talk

2025. g. 19. dec. 18:00 UTC

Tirgus saruna

Peļņas

Nike's Margin Outlook Shows Quarter-to-Quarter Improvement -- Market Talk

2025. g. 19. dec. 17:41 UTC

Peļņas

These Stocks Are Moving the Most Today: Oracle, Nike, Micron, DJT, Carnival, BioMarin, CoreWeave, Lamb Weston, and More -- Barrons.com

2025. g. 19. dec. 17:24 UTC

Tirgus saruna

Peļņas

Nike's North America Business is Bright Spot in Turnaround -- Market Talk

2025. g. 19. dec. 17:20 UTC

Tirgus saruna

Iegādes, apvienošanās, pārņemšana

Tech, Media & Telecom Roundup: Market Talk

2025. g. 19. dec. 17:20 UTC

Tirgus saruna

Financial Services Roundup: Market Talk

2025. g. 19. dec. 16:29 UTC

Peļņas

These Stocks Are Moving the Most Today: Oracle, Nike, FedEx, Micron, DJT, Carnival, BioMarin, Lamb Weston, Winnebago, and More -- Barrons.com

2025. g. 19. dec. 16:20 UTC

Iegādes, apvienošanās, pārņemšana

CPKC: Anticipates Submitting Comments to Surface Transportation Board in Accordance With Procedural Schedule

2025. g. 19. dec. 16:19 UTC

Iegādes, apvienošanās, pārņemšana

CPKC: Approval of Union Pacific-Norfolk Southern Merger Isn't Inevitable

2025. g. 19. dec. 16:18 UTC

Iegādes, apvienošanās, pārņemšana

CPKC: Will Be Thoroughly Reviewing Union Pacific-Norfolk Southern Merger Application Over Coming Days

2025. g. 19. dec. 16:16 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 19. dec. 16:16 UTC

Tirgus saruna

U.K. Public Borrowing Data Shows Slow Progress in Reducing Fiscal Deficit -- Market Talk

2025. g. 19. dec. 16:05 UTC

Iegādes, apvienošanās, pārņemšana

Trump Media Is Making a Big Pivot. Kodak Tried That, Too. -- Barrons.com

2025. g. 19. dec. 16:04 UTC

Iegādes, apvienošanās, pārņemšana

Trump Media Is Making a Big Pivot. Kodak Tried That, Too. -- Barrons.com

2025. g. 19. dec. 15:37 UTC

Tirgus saruna

U.S. Labor Market Weakness Could Cause Further Fed Rate Cuts -- Market Talk

2025. g. 19. dec. 15:21 UTC

Tirgus saruna

West-Coast Liquor Store Strike Weighed on Canada Retail Data -- Market Talk

2025. g. 19. dec. 15:09 UTC

Tirgus saruna

Gold Flat But Set for Weekly Gains -- Market Talk

2025. g. 19. dec. 15:09 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2025. g. 19. dec. 15:09 UTC

Peļņas

FedEx Earnings Were Strong. The Stock Is Down. -- Barrons.com

Salīdzinājums

Cenas izmaiņa

Vetoquinol SA Prognoze

Vērtējuma vienprātība

By TipRanks

0 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 0 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam Vetoquinol SA — pēdējo 3 mēnešu laikā.

Tehniskais rādītājs

By Trading Central

72.6 / 75.1Atbalsts un pretestība

Recent bearish events outweigh bullish events.

All events are bearish.

Noskaņojums

By Acuity

47 / 374 Rangs Veselības aprūpe

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par Vetoquinol SA

Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. It provides products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; infectious diseases; reproduction; behavior management; internal medicine; and cardiology-nephrology for cattle, sheep, pigs, poultry, dogs, cats, and horses. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA is a subsidiary of Soparfin SCA.